Promoting Competition
and Investment in the
U.S. Life Sciences Ecosystem
The U.S. life sciences ecosystem depends on mergers and acquisitions (M&A) to bring together the resources, investment and expertise needed to develop and deliver treatments and cures for patients.
FUELING COMPETITION AND INVESTMENT
M&A drives competition and investment across America's life sciences industry.
FACILITATING INNOVATION
Life sciences companies of all sizes engage in M&A to connect innovations with the resources needed to bring them to market.
DRIVING AMERICAN GROWTH, LEADERSHIP
M&A plays a critical role within America’s world-class life sciences industry.
U.S. biopharmaceutical companies headquartered in the U.S.
PARTNERS
ABOUT US
PULSE is a national coalition raising awareness about the unique and fundamental role of mergers and acquisitions (M&A) in America’s life sciences industry. M&A enables life sciences companies of all sizes to bring together resources, investment and expertise needed to develop and deliver new treatments and cures. PULSE members represent researchers, manufacturers and leaders of life sciences companies of all sizes that make up a diverse, vibrant life sciences industry across America.
LATEST NEWS
M&A Is Essential to Sustaining Life Sciences Momentum in 2026
Life sciences M&A activity gained momentum in late 2025, and that acceleration is expected to continue in 2026. This positive trend is vitally important for the many treatments and cures that depend on these partnerships to reach patients.
ICYMI: Congressional Briefing Spotlights Value of Life Sciences M&A
New research presented at a Congressional staff briefing highlighted the strong, positive relationship between pharmaceutical mergers and acquisitions (M&A) and the launches of new drugs for patients. Research Finds that Pharmaceutical M&A Drives New, Novel...
2H 2025 Highlights – Partnership for the U.S. Life Science Ecosystem (PULSE)
This year, life sciences mergers and acquisitions (M&A) played a crucial role in driving innovation and supporting America’s global leadership in the life sciences.